I passed the article on to my Dr. at City of Hope, I'll ask

New Post Public Reply Private Reply Replies (0) Message Board
GaryM moxaman #9417
619
I passed the article on to my Dr. at City of Hope, I'll ask him his thoughts about it when I see him next month. As I see it, cannabis based products may have a role in achieving remission.

To me the question is what's needed to sustain the remission. I remain on Chemo, and may for the rest of my life, because of the fact that they know that a much higher percentage of patients will come out of remission if they don't continue on the chemo. Perhaps cannabis could replace chemo in sustaining remissions, but the problem is, if it doesn't, can they do it again.

If OWCP's sublingual tablet, or another way of administering cannabis, could bring remissions quicker, that should be verified in trials in a few years. On the other hand, the question of sustaining remissions could take many years, or decades to verify when compared with remaining on chemo. I frankly would love to get off the chemo, if it were safe to do so, but the data to date says, stay on it. At my age the Dr. doesn't want to take chances that would require putting me back in remission. Many leading cancer institution's wouldn't do stem cells at my age, and during treatment I've met several people from all over the U.S. who were my age, or older and were successful at COH with stem cells after being turned down at other top notch institutions.

My Dr. has also been a leader at T-cell research. I met a patient who came out of remission after about 5 years who received stem cells the same day I did, but they were his own, two days later he got his modified T-cells as well, he was doing great and seeing the Dr. less frequently than I did because the concern of rejection from his own cells wasn't a concern. If the day comes where they could harvest your own stem cells and eliminate any defective ones the entire process of stem cell transplantation's would be greatly simplified, as rejection could largely eliminated. I do believe this will be more likely in the future, but for now it's dependent on finding the best match. I hope that cannabis based drugs play a part in making this process better as well, but by itself, it won't be the cure.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 22

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 77

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
Dolby's Strong Quarter Meets a Flat 2027 Reality Check

Updated Category News Views 92

A licensing machine just coughed up a very good quarter, then told investors not to expect the engine to accelerate next year. That is the whole Dolby story in one uncomfortable breath. NYSE:DLB finished fiscal 2026 with fourth-quarter revenue of $374 million, up from $307 million a year earlier, while GAAP diluted earnings climbed to $0.86 from $0.51. Those are not...

Continue Reading
Novo and nference Push Whole-Body Data Into Research

Updated Category News Views 26

Cardiometabolic medicine has spent too long staring at single numbers while the rest of the body keeps waving its arms. Novo Nordisk’s newly announced collaboration with nference is an attempt to widen that lens, combining Novo’s clinical-trial research with nference’s AI technology and federated healthcare data network. The target is not small: obesity, diabetes,...

Continue Reading
Cold-Season Cleaning Advice Has a Practical Catch!

Updated Category News Views 11

Remote Controls Are Nobody’s First Suspect A television remote can make the rounds all evening and never see a cloth, which is precisely why Maid Brigade’s cold-and-flu-season reminder lands as common sense rather than revelation. The Scottsdale cleaning company is telling households to look past the usual kitchen counter and bathroom sink routine. Fair enough. People...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 26

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 183

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 57

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 239

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading

Top 5 Most Recently Viewed Articles

Laser Photonics CMS Expands Their Market Presence with New Orders

Updated Category News Views 145

Laser Photonics CMS Expands Their Market Presence with New Orders Laser Photonics Corporation (NASDAQ: LASE), a prominent global player in the manufacturing of innovative industrial laser systems, has announced recent progress from its subsidiary, Control Micro Systems (CMS). This exciting development highlights the increasing applications of laser technology in various...

Continue Reading
WuXi Biologics Expands Operations with New Syringe Production Line

Updated Category News Views 221

WuXi Biologics Expands Production Capabilities WuXi Biologics (2269.HK), a renowned global Contract Research, Development, and Manufacturing Organization (CRDMO), is set to strengthen its product capabilities by launching a new sterile filling line designed specifically for prefilled syringes (PFS). This initiative is taking place at WuXi's facility in Leverkusen,...

Continue Reading
Unlocking the Future: SEALSQ's MS6003 Secure Element Launch

Updated Category News Views 232

Revolutionizing Secure Authentication with MS6003 SEALSQ Corp (NASDAQ: LAES), a leader in semiconductor innovation, has recently announced a significant addition to its product portfolio: the MS6003 secure element chip. This state-of-the-art chip is equipped with a preloaded FIDO2 application, marking a pivotal step towards enhancing passwordless authentication in an era...

Continue Reading
Boeing's Outlook Brightens Amid Trade Deal Backlogs

Updated Category News Views 197

Boeing's Promising Trade Developments Boeing Co.'s earnings call showcased a significant shift in the global trade landscape, influenced by recent agreements during the Trump administration. This transition is likely to ease tariff pressures, providing vital support for the aerospace giant’s impressive backlog that currently exceeds $600 billion. The Financial Snapshot...

Continue Reading
Supreme Court's Decision on Appian vs. Pegasystems Verdict Case

Updated Category News Views 407

Supreme Court to Review Appian's Petition Against Pegasystems The Supreme Court of Virginia has decided to hear a significant legal case involving Appian and Pegasystems, Inc., which revolves around a staggering judgment amounting to $2.036 billion. This case is crucial as it pertains to the protection of intellectual property and trade secrets in the tech industry....

Continue Reading